关键信息
-
基因名
RALB
- 应用
-
别名
5730472O18Rik; dRalb; GTP binding protein; Ralb; RALB_HUMAN; RAS like protein B; RAS like proto oncogene B; Ras related GTP binding protein B; Ras-related protein Ral-B; v ral simian leukemia viral oncogene homolog B (ras related GTP binding protein); v ral simian leukemia viral oncogene homolog B (ras related); V ral simian leukemia viral oncogene homolog B
-
种属
Human
-
表达系统
E. coli
-
标签
N- GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P11234
-
表达区间
1-206aa
-
分子量
50.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
RALB, a member of the Ral family of small GTPases, plays a critical role in various cellular processes, including cell proliferation, survival, and differentiation. As a key regulator of signaling pathways, RALB is implicated in cancer biology, particularly in promoting oncogenic signals that contribute to tumorigenesis and metastasis. Its activation is often associated with several malignancies, making it a potential biomarker for cancer diagnosis and a promising target for therapeutic intervention. Recent research has also highlighted RALB's involvement in modulating the immune response and its potential role in chronic inflammatory conditions. The study of RALB recombinant proteins has emerged as a significant area of interest for scientists seeking to better understand the molecular mechanisms underlying its activity and interactions within the cell. By creating RALB recombinant proteins, researchers can investigate the structural and functional aspects of this GTPase, providing insights into its role in health and disease. Additionally, these proteins serve as valuable tools for screening potential small molecule inhibitors that may disrupt RALB signaling pathways, offering hope for novel cancer therapies. Overall, the ongoing research on RALB recombinant proteins is crucial for advancing our knowledge of its biological functions and therapeutic potential, paving the way for innovative strategies in cancer treatment and other diseases related to aberrant RALB activity.
